News

Salix has a license to the HIV-associated diarrhea indication for Crofelemer and the additional indications of pediatric diarrhea and acute infectious diarrhea in North America, Europe and Japan.

The capsules are rich in antioxidants and probiotics for digestive health from over 20 different vitamins and minerals, and can either be swallowed as pills or opened and

The company claims that energy bar utilises the highest quality 100% natural, organic ingredients that are Organic and Kosher certified ingredients. Active X energy bars is available in

MMRF’s Personalized Medicine Initiative has been developed to allow molecular characterization of multiple myeloma patients and thus enforce the development of new, targeted treatments. Onyx is believed to

Under the contract, SRI will carry on with the development of NIAID’s Division of Microbiology and Infectious Diseases (DMID) program that involves translation of basic research into clinical

The patent named ‘Mammalian cell lines for increasing longevity and protein yield from a cell culture’ provides coverage until 2025. It covers improved cell lines of greater longevity,

Following the approval for sNDA, the capsules’ labeling will feature clinical safety and efficacy data for Vancocin in treating currently circulating strains of Clostridium difficile, including the BI/NAP1

The collaboration will help various countries across the globe in making them self-sufficient in the manufacture of vital biopharmaceuticals such as vaccines, insulin and biosimilars, thus reducing the

Kymos plans to take up research activities in a new immunology laboratory that will be opened in the Barcelona Science Park (PCB) in early January 2012, conducting regulatory